Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence

NCT01549652 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01549652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01549652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2011
Completion date
October 31, 2016
Enrollment
133 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid withdrawal, physical dependence